[Evaluation of the efficacy of and tolerance of betamethasone 17,21 dipropionate and salicylic acid in dermatoses of the scalp].
D000328:Adult; D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000627:therapeutic use*; D012536:Scalp Dermatoses / Q000188:drug therapy*
D004338:Drug Combinations; D012459:Salicylates; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone
Valutazione dell'efficacia e tollerabilità del betametasone 17,21 dipropionato e acido salicilico nelle dermatosi del cuoio capelluto.